During the past decade, Uddevalla Sjukhus conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Uddevalla Sjukhus" #1 sponsor was "Karolinska Institutet" with 1 trials, followed by "Nordic Lymphoma Group" with 1 trials sponsored, "Sangart" with 1 trials sponsored, "Sierra Oncology, Inc." with 1 trials sponsored and "Uppsala University" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Uddevalla Sjukhus" #1 collaborator was "Nordic Cancer Union" with 1 trials as a collaborator, "Roche Pharma AG" with 1 trials as a collaborator, "Swedish Cancer Foundation" with 1 trials as a collaborator and "The Swedish Research Council" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Uddevalla Sjukhus" are "Breast Cancer" (1 trials), "DLBCL" (1 trials), "Diffuse Large B Cell Lymphoma" (1 trials), "Hypotension" (1 trials) and "Ischemia" (1 trials). Many other conditions were trialed in "Uddevalla Sjukhus" in a lesser frequency.

Most popular intervention types in "Uddevalla Sjukhus" are "Drug" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "CT or PET scans" (1 trials), "Danazol" (1 trials), "Hemospan (MP4OX)" (1 trials), "Momelotinib" (1 trials) and "Omission of axillary clearance" (1 trials). Other intervention names were less common.

The vast majority of trials in "Uddevalla Sjukhus" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Uddevalla Sjukhus". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Uddevalla Sjukhus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Uddevalla Sjukhus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".